Axsome Therapeutics Inc • AXSM
Capital at risk.
About Axsome Therapeutics Inc
Ticker
Trading on
ISIN
Industry
Sector
CEO
Headquarters
Employees
Website
Analyst Insights & forecasts
100% Buy
0% Hold
0% Sell
Based on information from 17 analysts.
Average price target
Sentiment analysis
-1.5
Extreme greed
+1.5
0.88
Last 30 days
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.
Build your future fund today!
Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!
Capital at risk.
FAQs
Axsome Therapeutics Inc shares are currently traded for undefined per share.
Axsome Therapeutics Inc currently has 48.8M shares.
No, Axsome Therapeutics Inc doesn't pay dividends.
Axsome Therapeutics Inc 52 week high is $139.13.
Axsome Therapeutics Inc 52 week low is $64.11.
Axsome Therapeutics Inc 200-day moving average is $91.85.
The CEO of Axsome Therapeutics Inc is Dr. Herriot Tabuteau M.D..
Axsome Therapeutics Inc has 683 employees.
The market cap of Axsome Therapeutics Inc is $6.07B.
The current P/E of Axsome Therapeutics Inc is null.
The EPS of Axsome Therapeutics Inc is -$5.98.
The PEG Ratio of Axsome Therapeutics Inc is 0.
According to the analysts Axsome Therapeutics Inc is considered a buy.